Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts

Immunology Letters

Volumn 109, Issue 1, 2007, Pages 21-27

  Jung, Young Ok ^a   Cho, Mi La ^b   Kang, Chang Min ^b   Jhun, Joo Yeon ^b   Park, Jin Sil ^b   Oh, Hye Joa ^b   Min, Jun Ki ^b   Park, Sung Hwan ^b   Kim, Ho Youn ^b  

^a Hallym University   (South Korea)

^b The Rheumatism Research Center RhRC   (South Korea)

Author keywords

Fibroblast like synoviocyte; IL 15; Inflammation; Rheumatoid arthritis; Toll like receptor

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCLONAL ANTIBODY; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SUPERNATANT; SYNOVIOCYTE; SYNOVIUM; UPREGULATION;

ANTIBODIES; ARTHRITIS, RHEUMATOID; FIBROBLASTS; HUMANS; INTERLEUKIN-15; NF-KAPPA B; SESQUITERPENES; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 33847680512     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.12.006     Document Type: Article

References (43)

1. Weyand C.M., and Goronzy J.J. Pathogenesis of rheumatoid arthritis. Med Clin North Am 63 (1997) 696-702
2. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 (2003) 356-361
3. Firestein G.S., and Zvaifler N.J. How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end. Arthritis Rheum 46 (2002) 298-308
4. van der Heijden I.M., Wilbrink B., Tchetverikov I., Schrijver I.A., Schouls L.M., Hazenberg M.P., et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 43 (2000) 593-598
5. Sobek V., Birkner N., Falk I., Wurch A., Kirschning C.J., Wagner H., et al. Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res Ther 6 (2004) R433-R446
6. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
7. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
8. Underhill D.M., Ozinsky A., Smith K.D., and Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 96 (1999) 14459-14463
9. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
10. Zhang F.X., Kirschning C.J., Mancinelli R., Xu X.P., Jin Y., Faure E., et al. Bacterial lipopolysaccharide activates unclear factor-κB through interleukin-1 signalling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274 (1999) 7611-7614
11. Ohashi K., Burkart V., Flohe S., and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J Immunol 164 (2000) 558-561
12. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J Exp Med 195 (2002) 99-111
13. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276 (2001) 10229-10233
14. Seibl R., Birchler T., Loeliger S., Hossle J.P., Gay R.E., Sauremnann T., et al. Expression and regulation of toll like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 162 4 (2003) 1221-1227
15. Radstake T.R., Roelofs M.F., Jenniskens Y.M., Oppers-Walgreen B., van Riel P.L., Barrera P., et al. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokine interleukin-12 and interleukin-18 via interferon-γ. Arthritis Rheum 50 12 (2004) 3856-3865
16. Dubois S., Mariner J., Waldmann T.A., and Tagaya Y. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17 (2002) 537-547
17. Giri J.G., Kumaki S., Ahdieh M., Friend D.J., Loomis A., Shanebeck K., et al. Identificaiton and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J 14 (1995) 3654-3663
18. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264 (1994) 965-968
19. Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391 (1998) 700-703
20. McInnes I.B., Leung B.P., Sturrock R.D., Field M., and Liew F.Y. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med 3 (1997) 189-195
21. Sebbag M., Parry S.L., Brennan F.M., and Feldmann M. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Eur J Immunol 27 (1997) 627-632
22. Ruchatz H., Leung B.P., Wei X.Q., McInnes I.B., Liew F.Y., McInnes I.B., et al. Soluble IL-15 receptor-α chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 160 (1996) 5654-5660
23. Baslund B., Tvcde N., Danneskiold-Samsoe B., Larsson P., Panayi G., Petersen J., et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 52 (2005) 2686-2692
24. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
25. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
26. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 (2004) 499-511
27. Liew F.Y., Xu D., Brint E.K., and O'Nell L.A.J. Negative regulation of toll-like receptor mediated immune responses. Nat Rev Immunol 5 6 (2005) 446-458
28. Kyburz D., Rethage J., Seibl R., Lauener R., Gay R.E., Carson D.A., et al. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48 (2003) 642-650
29. Frasnelli M.E., Tarussio D., Chobaz-Peclat V., Busso N., and Alexander S. TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Res Ther 7 (2005) R370-R379
30. Re F., and Strominger J.L. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 173 (2004) 7548-7555
31. Thoma-Uszynski S., Kiertscher S.M., Ochoa M.T., Bouis D.A., Norgard M.V., Miyake K., et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 165 (2000) 3804-3810
32. Gao J.J., Zuvanich E.G., Xue Q., Horn D.L., Silverstein R., and Morrison D.C. Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol 163 (1999) 4095-4099
33. Yi A.J.M., Tiib H.G., Hong S.C., Redford T.W., and Krieg A.M. Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-α production through activation of NK-κB. Int Immunol 13 (2001) 1391-1404
34. Waldmann T.A., and Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17 (1999) 19-49
35. Zhang X., Sun S., Hwang L., Tough D.F., and Sprent J. Potent and selective stimulation of memory-phenotype CD8+ cells in vivo by IL-15. Immunity 8 (1998) 591-599
36. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9 (1998) 669-676
37. Harada S., Yamamura M., Okamoto H., Morita Y., Kawashima M., Aita T., et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 42 (1999) 1508-1516
38. McInnes I.B., al-Mughales J., Field M., Leung B.P., Huang F.P., Dixon R., et al. The role of interleukine-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 2 (1996) 175-182
39. Groh V., Bruhl A., El-Gavalawy H., Nelson J.L., and Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 100 (2003) 9452-9457
40. Verri Jr. W.A., Cunha T.M., Parada C.A., Wei X., Ferreira S.H., Liew F.Y., et al. IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-γ, endothelin and prostaglandin. Proc Natl Acad Sci USA 103 (2006) 9721-9725
41. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2 (2002) 364-371
42. Miossec P. An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 16 (2004) 218-222
43. Vanags D., Williams B., Johnson B., Stephen H., Nash P., Taylor A., et al. Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet 368 (2006) 855-863